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Aim To obtain correct evaluation of the prevalence rate 
of diabetes mellitus and impaired fasting glycemia (IFG) in 
Hungary.
Method The study was performed on a nationally repre-
sentative sample covered by the Hungarian General Prac-
titioners’ Morbidity Sentinel Stations Program. The source 
population consisted of all persons aged 20-69 years who 
were registered with the participating centers. The preva-
lence rates were adjusted to age and sex distribution of the 
total Hungarian population. Fasting blood samples of 1803 
participants were evaluated. Response rate was 90.7%.
Results In addition to 130 (7.21%) patients with established 
diabetes, 26 participants with newly diagnosed diabetes 
were found, resulting in a total crude diabetes prevalence 
of 8.65% (men: 11.16%; women: 6.41%; P < 0.001). After 
weighting for age and sex, the prevalence rate of diabe-
tes in participants aged 20-69 years should be set at 7.47% 
(95% confidence interval [CI], 6.26-8.69) (men: 9.49%; 95% 
CI, 7.52-11.46; women: 5.58%; 95% CI, 4.12-7.04). In addition 
to 41 (2.27%) patients with established IFG (fasting blood 
glucose: 6.1-6.9 mmol/L), 47 participants with newly diag-
nosed IFG were found, resulting in a total crude IFG preva-
lence of 4.88% (men: 6.11%; women: 3.78%; P = 0.022). After 
making corrections for weighting age and sex, the total IFG 
prevalence rate in participants aged 20-69 years should be 
set at 4.39% (95% CI, 3.44-5.34) (men: 5.52%; 95% CI, 3.99-
7.06; women: 3.33%; 95% CI, 2.19-4.47).
Conclusion The prevalence rate of diabetes and IFG in 
Hungary is higher than previously estimated by experts 
and authorities. The present data may serve as a base for 
comparative investigations in the future.
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The importance of diabetes mellitus and other forms of 
glucose intolerance in public health has dramatically in-
creased worldwide (1-3). Not only the recent prevalence 
rate but the estimated increase in incidence may create a 
global health problem in the near future (4). In order to es-
tablish effective prevention and control programs, the ex-
act number of the affected people should be known.
Type 2 diabetes is the predominating form of diabetes mel-
litus. Typically, type 2 diabetes evolves without major clinical 
symptoms and prediabetes or intermediate hyperglycemia 
(impaired fasting glycemia [IFG] and impaired glucose toler-
ance) precedes the manifestation (5-7). Accordingly, screen-
ing for identifying asymptomatic participants with diabe-
tes or prediabetes is of great clinical importance (8). Several 
screening procedures with different methods in various set-
tings were applied in order to detect participants with type 2 
diabetes, prediabetes, or metabolic syndrome among adult 
people in Hungary. Nevertheless, only a representative sur-
vey should be considered reliable for determining the real 
prevalence rate of diabetes in a given population.
Regarding the prevalence rate of diabetes in Hungary, in-
stead of confirmed data, at present only estimations from 
experts and authorities are available. In previous and cur-
rent versions of Diabetes Atlas (3rd edition, 2006; 4th edi-
tion, 2009) published by the International Diabetes Federa-
tion (9,10), diabetes prevalence in Hungary was determined 
by extrapolating data from Polish studies (11,12), due to the 
lack of reliable data.
In 2005-2006, a representative survey was initiated by the 
Hungarian Diabetes Association in cooperation with the 
national health monitoring program established by the 
School of Public Health, Medical University of Debrecen 
(13). The aim of the study was to determine the prevalence 
rate of the metabolic syndrome, diabetes, and IFG in a rep-
resentative cohort of people aged 20-69 years in Hungary. 
Data about diabetes and IFG are presented here.
METHodS
We performed a cross-sectional study in the population cov-
ered by the Hungarian General Practitioners’ Morbidity Sen-
tinel Stations Program. The design of the sentinel stations 
program has already been described (14). Briefly, participat-
ing general practitioners (GP) from different counties con-
tinuously report new cases of non-communicable diseas-
es of major public health importance diagnosed using 
standardized diagnostic criteria. In the present study, 
8 out of 19 counties were selected in order to represent dif-
ferent geographical and socio-economical regions (urban/
rural, western/eastern, higher/lower economical status ar-
eas). Finally, 59 GPs from 8 counties (Baranya, Bács-Kiskun, 
Győr-Moson-Sopron, Hajdú-Bihar, Heves, Komárom-Eszter-
gom, Szabolcs-Szatmár-Bereg, Zala) participated voluntarily 
in this survey. GPs and their nurses were trained in advance 
by members of the Department of Preventive Medicine 
(Faculty of Public Health, University of Debrecen). During the 
entire screening procedure, quality control and supervision 
were provided by county medical officers.
Study sample
The source population of this study consisted of all per-
sons aged 20-69 years who were registered with the par-
ticipating GPs on December 31, 2005. As the proportion of 
the population registered with GPs in Hungary is virtually 
100%, it enabled us to provide an accurate population de-
nominator. Using an initial calculation, the total number of 
participants for screening was set at 2006. This number en-
abled us to detect high-density lipoprotein (HDL)-choles-
terol, the component of the metabolic syndrome with the 
lowest prevalence rate (4.8%) and a margin of 20%-25% 
(15). According to the criteria of representativeness, par-
ticipants living in the 8 counties and corresponding to the 
structure of the Hungarian adult population were consid-
ered. In other words, the population was representative for 
the overall Hungarian population in terms of age and sex. 
The particular participants were randomly selected from 
the files of residents in the catchment area. With an overall 
response rate of 90.7%, 1819 participants were screened 
but due to lacking samples, 1803 participants were finally 
analyzed (Table 1). As some misrepresentations occurred 
in the screened population (lower than expected partici-
pation in younger age groups and higher participation in 
older age groups), a weighted estimation of age and sex 
was used in order to correct the disproportional represent-
ativeness of some age- and sex- specific strata in the sam-
ple. Accordingly, crude rate (results of initial evaluation of 
data) and corrected rate (weighted estimation by age and 
sex) are reported. In addition, the absolute number of pa-
tients with diabetes or IFG was assessed based on the total 
number (n=6 872 843) of the Hungarian population aged 
20-69 years on December 31, 2006 (Table 1).
data collection and evaluation
Participants were invited by their GPs to join the survey. 
The relevant data on medical history, presence of diseas-
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es, and mode of treatment were registered by the GPs. A 
physical examination including measurement of weight, 
height, waist circumference, and blood pressure was car-
ried out by the GPs. Fasting venous blood samples were 
taken to determine serum triglycerides, HDL-cholesterol, 
and plasma glucose levels. Laboratory measurements of 
all samples were performed by the same institute (Depart-
ment of Clinical Chemistry, University of Debrecen). Waist 
circumference >88 cm in women and >102 cm in men was 
considered abnormal (16).
Diabetes (type 1 or 2) and IFG were considered known 
if the diagnosis was documented in the patient’s file. 
The diagnosis of previously unknown (newly diagnosed) 
diabetes or IFG was based on the criteria of the World 
Health Organization (WHO) (17). Accordingly, diabetes 
was diagnosed if fasting blood glucose values reached 
or exceeded 7.0 mmol/L. IFG was determined with fast-
ing blood glucose values ranging between 6.1 and 6.9 
mmol/L. In addition, IFG was also assessed according to 
the American Diabetes Association (ADA) criteria (fasting 
blood glucose, 5.6-6.9 mmol/L) (18). In this epidemiologi-
cal survey, no oral glucose tolerance test was performed 
and confirmatory fasting blood glucose values were not 
available.
The survey was approved by the Ethics Committee of 
University of Debrecen and participants gave informed 
consent. The results of the survey were reported to the 
GPs and therapeutic suggestions were also made if 
needed.
Statistical analysis was performed using the Stata program 
(StataCorp LP, College Station, Tx, USA). Data are presented 
as mean values and standard deviation (x±SD). The correct-
ed prevalence rates are expressed as mean and 95% confi-
dence interval (CI). Continuous variables were compared by 
using unpaired t-test while categorical variables were com-
pared by χ2 test. The level of significance was set at P < 0.05.
RESulTS
The overall response rate in this survey was as high as 90.7% 
(1819 out of 2006 randomly selected and invited partici-
pants). Due to technical difficulties (insufficient number of 
questionnaires, lacking blood samples), data of 1803 partici-
pants (851 men and 952 women) were finally analyzed. Wom-
en had a higher age (46.7 ± 13.5 vs 45.0 ± 13.7 years; P < 0.010) 
and a lower body mass index (27.5 ± 5.8 vs 27.9 ± 5.0 kg/m2; 
P = 0.043), as well as a smaller waist circumference (93.1 ± 15.6 
vs 99.4 ± 14.0 cm; P < 0.0001) than men. Abnormal waist cir-
cumference was more often found in women than men 
(57.1 vs 37.9%; P < 0.001). On the other hand, the prevalence 
rate of obesity (body mass index >30 kg/m2) was nearly the 
same in women and men (30.9 vs 30.3%; P = 0.764).
There were 130 participants (7.21%) with known diabe-
tes. Previously unknown (newly diagnosed) diabetes was 
found in 26 participants (1.44%), resulting in a total crude 
prevalence rate of diabetes as high as 8.65% (men: 11.16%, 
women: 6.41%; P < 0.001). After making corrections, the 
prevalence rate of diabetes in participants aged 20-
69 years should be set at 7.47% (95% CI, 6.26-8.69) 
TAblE 1. Age and sex distribution in the sample, in the investigated 8 counties, and in the Hungarian population aged 20-69 y 
(december 31, 2006)*
Percentage of participants
Age-groups 
(years)
sample assessed 
(n = 1803)
population of the investigated counties 
(n = 2 331 587)
Hungarian population aged 20-69 
(n = 6 872 843)
Men: n = 851 n = 1 143 173 n = 3 344 572
20-29 18.0 21.9 21.6
30-39 18.9 23.9 24.2
40-49 20.9 19.9 19.2
50-59 24.3 21.3 21.5
60-69 17.9 12.9 13.5
Women: n = 952 n = 1 188 414 n = 3 528 271
20-29 14.8 20.3 19.8
30-39 16.9 21.9 22.2
40-49 22.1 19.1 18.4
50-59 25.3 22.3 22.6
60-69 20.9 16.4 17.0
*Source: Central office for Administrative and Electronic Public Services.
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(men: 9.49%; 95% CI, 7.52-11.46; women 5.58%; 95% CI, 
4.12-7.04). In this way, the absolute number of patients 
with diabetes in the total Hungarian population aged 20-
69 years was established to be 513 455.
There were 41 participants (2.27%) with known IFG (fasting 
blood glucose: 6.1-6.9 mmol/L). Previously unknown (newly 
diagnosed) IFG was found in 47 participants (2.61%), result-
ing in a total crude prevalence rate of IFG as high as 4.88% 
(men: 6.11%, women: 3.78%; P = 0.022). After making cor-
rections, the prevalence rate of IFG in participants aged 20-
69 years was set at 4.39% (95% CI, 3.44-5.34) (men: 5.52%; 
95% CI, 3.99-7.06; women: 3.33%; 95% CI, 2.18-4.47). When 
the ADA criterion was used for IFG determination (fast-
ing blood glucose 5.6-6.9 mmol/L), the total crude preva-
lence rate of IFG was 8.82% (men: 11.28%, women: 6.62%; 
P < 0.001); corrected total prevalence rate 8.00% (95% CI, 
6.74-9.25) (men: 10.27%; 95% CI, 8.23-12.32; women: 5.86%; 
95% CI, 4.37-7.36). In this way, the absolute number of par-
ticipants with IFG in the total Hungarian population aged 
20-69 years was established to be 301 936 (WHO criteria) or 
549 551 (ADA criteria).
The prevalence rate of diabetes (known and newly diag-
nosed) increased with age, while that of IFG (known and 
newly diagnosed) increased up to the 50-59 years age 
group and declined beyond (Figure 1).
No significant variation in the prevalence of diabetes was 
observed between the counties (it ranged from 6.90% in 
Baranya county to 12.28% in Zala county; P = 0.464).
There was a wide variation in the prevalence of IFG (WHO 
criteria) between the counties (it ranged from 1.75% in 
Baranya county to 8.94% in Heves county; P = 0.018).
diSCuSSioN
Our study showed that the prevalence of diabetes in Hun-
garian population aged 20-69 years was 7.47% (95% CI, 
6.26-8.69) and the prevalence of IFG was 4.39% (95% CI, 
3.44-5.34). These rates are higher than previously estimat-
ed by Hungarian experts and authorities. 
Obviously, the results of a screening procedure depend on 
the participants selected, the response rate achieved, and 
the method used. In our study, the size and the structure of 
the sample population were determined well in advance. 
The selection followed the epidemiological rules for ob-
taining a sample of 2006 participants who should be con-
sidered representative of a population aged 20-69 years in 
Hungary. The response rate of 90.7% in our screening pro-
cedure was appropriate. Although oral glucose tolerance 
test with fasting and 2-hour glucose values has been wide-
ly used in the clinical practice for detecting glucose intol-
erance in asymptomatic subjects, an epidemiological sur-
vey should be based on fasting blood glucose values only. 
In addition, the use of confirmatory blood glucose values 
should not be considered mandatory in epidemiological 
studies (17). Clearly, by using fasting blood glucose values 
for screening, participants with impaired glucose tolerance 
could not be identified.
Classification of diabetes was not performed in this study 
although it is generally known that the predominant type 
of diabetes is type 2 (10).
The prevalence rate of diabetes and IFG was greater in men 
than in women. Our results did not provide explanation for 
the difference. The age-dependency in the prevalence rate 
of diabetes in our study corresponds to the results of other 
investigations (18).
The number of participants with IFG nearly doubled when 
we used ADA criteria as compared with WHO criteria. Un-
doubtedly, a pandemic of prediabetes can be created by 
lowering the diagnostic threshold of IFG from 6.1 to 5.6 
mmol/L (19).
In our study, the prevalence of known diabetes was high-
er than that of the newly diagnosed diabetes (previously 
unknown). The proportion of undiagnosed persons with 
Figure 1.
Prevalence rate of diabetes mellitus and impaired fasting glycemia (IFG) in differ-
ent age groups of participants screened (n = 1803). Open bars – IFG; closed bars 
– diabetes.
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diabetes proved to be 0.3 or 0.7 in surveys, depending on 
the method used (20,21). The low proportion (0.2) of undi-
agnosed persons with diabetes in our study can partly be 
explained by the fact that no oral glucose tolerance test 
was performed.
This survey provided new epidemiological data about dia-
betes and IFG in Hungary. Although a former study also in-
vestigated some epidemiological characteristics of diabe-
tes in Hungary (14), the number of counties involved was 
smaller, no nation-wide data were provided, IFG was not 
studied, and the diagnostic criteria for diabetes were based 
on former diagnostic criteria. In this way, the epidemiology 
of diabetes and IFG in Hungary was better characterized in 
the present study.
The results of our study are in accordance with other stud-
ies performed recently in Central Europe, despite some dif-
ferences in the structure of the population and the screen-
ing method used. Namely, the prevalence rate of diabetes 
in Slovakia was 7.0% and the prevalence rate of type 2 dia-
betes in Croatia was 6.1% (20,21). Similar results have been 
found recently in southern Poland (22). The prevalence 
rate of IFG in our study was much lower (4.39%) than that 
(11.3%) reported in Croatia (20).
Our study has some limitations. Although it was designed 
as a representative survey, some misrepresentations oc-
curred in the screened population and, therefore, correc-
tions should be made. In addition, no oral glucose tol-
erance test was performed and, accordingly, it can be 
assumed that some patients with diabetes could not be 
identified and participants with impaired glucose toler-
ance could not be detected. Nevertheless, epidemiologi-
cal surveys could be based on measuring fasting glucose 
values only. Strength of our study is the high overall re-
sponse rate, centrally measured laboratory parameters, 
and the quality control performed.
Taken altogether, our study provided reliable data about 
the prevalence of diabetes and IFG in Hungarian popula-
tion aged 20-69 years. All prevalence rates proved to be 
higher than previously estimated. The present data may 
serve as a base for comparative investigations in the future.
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